These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 15628613

  • 1. Methylphenidate an effective treatment for ADHD?
    McDougle CJ.
    J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of hyperactivity in children with pervasive developmental disorders.
    Scahill L, Pachler M.
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):59-62. PubMed ID: 17284238
    [No Abstract] [Full Text] [Related]

  • 3. A prospective open trial of guanfacine in children with pervasive developmental disorders.
    Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B.
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):589-98. PubMed ID: 17069547
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Autism and attention deficit hyperactivity disorder: pharmacological intervention].
    Fernández-Jaén A, Martín Fernández-Mayoralas D, Fernández-Perrone AL, Calleja-Pérez B, Muñoz-Jareño N, López-Arribas S.
    Rev Neurol; 2013 Sep 06; 57 Suppl 1():S205-10. PubMed ID: 23897149
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
    Biederman J, Spencer T, Wilens T.
    Int J Neuropsychopharmacol; 2004 Mar 06; 7(1):77-97. PubMed ID: 14733627
    [Abstract] [Full Text] [Related]

  • 16. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
    Palumbo DR, Sallee FR, Pelham WE, Bukstein OG, Daviss WB, McDERMOTT MP, CAT STUDY TEAMDrs. Palumbo and McDermott are with University of Rochester; Dr. Sallee is with University of Cincinnati; Dr. Pelham is with State University of New York at Buffalo; Dr. Bukstein is with University of Pittsburgh; and Dr. Daviss is with University of Texas Health Science Center at San Antonio..
    J Am Acad Child Adolesc Psychiatry; 2008 Feb 06; 47(2):180-188. PubMed ID: 18182963
    [Abstract] [Full Text] [Related]

  • 17. Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.
    Biederman J.
    J Clin Psychiatry; 2006 Feb 06; 67 Suppl 8():4-6. PubMed ID: 16961423
    [No Abstract] [Full Text] [Related]

  • 18. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG, Binder C, Turgay A.
    J Child Adolesc Psychopharmacol; 2004 Feb 06; 14(2):243-54. PubMed ID: 15319021
    [Abstract] [Full Text] [Related]

  • 19. Use of medication in pervasive developmental disorders.
    Sloman L.
    Psychiatr Clin North Am; 1991 Mar 06; 14(1):165-82. PubMed ID: 1675463
    [Abstract] [Full Text] [Related]

  • 20. Treatment of attention-deficit-hyperactivity disorder.
    Elia J, Ambrosini PJ, Rapoport JL.
    N Engl J Med; 1999 Mar 11; 340(10):780-8. PubMed ID: 10072414
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.